SureTrader
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

Tilator- These are the only companies with XR approvals...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
wimuskyfisherman Member Profile
 
Followed By 5
Posts 1,250
Boards Moderated 0
Alias Born 11/26/14
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/16/2018 6:32:05 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 11:13:52 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/14/2018 6:54:36 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/9/2018 8:08:58 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/24/2018 8:04:28 AM
Intellipharmaceutics Provides Operational Update GlobeNewswire Inc. - 1/24/2018 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/5/2017 8:05:20 AM
Intellipharmaceutics Announces Receipt of Nasdaq Notice GlobeNewswire Inc. - 12/5/2017 8:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/4/2017 5:21:01 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/30/2017 10:51:14 AM
Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical GlobeNewswire Inc. - 11/30/2017 10:45:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/20/2017 5:20:34 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 10/18/2017 3:20:22 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/16/2017 6:03:43 AM
Intellipharmaceutics Announces Closing of US$4 Million Financing GlobeNewswire Inc. - 10/13/2017 5:45:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/13/2017 6:04:15 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/12/2017 4:07:48 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/11/2017 8:07:45 AM
Intellipharmaceutics Announces US$4 Million Registered Direct Offering GlobeNewswire Inc. - 10/11/2017 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/10/2017 5:25:56 PM
Intellipharmaceutics Announces Third Quarter 2017 Results GlobeNewswire Inc. - 10/10/2017 5:20:59 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/25/2017 7:12:00 AM
Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDA GlobeNewswire Inc. - 9/25/2017 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/20/2017 5:18:47 PM
Intellipharmaceutics Announces Receipt of Nasdaq Notice GlobeNewswire Inc. - 9/20/2017 5:10:00 PM
wimuskyfisherman   Friday, 11/10/17 07:42:50 PM
Re: wimuskyfisherman post# 31217
Post # of 32856 
Tilator- These are the only companies with XR approvals...

QUETIAPINE FUMARATE QUETIAPINE FUMARATE A090681 TABLET, EXTENDED RELEASE ORAL EQ 150MG BASE AB ACCORD HEALTHCARE INC
RX QUETIAPINE FUMARATE QUETIAPINE FUMARATE A202939 TABLET, EXTENDED RELEASE ORAL EQ 150MG BASE AB INTELLIPHARMACEUTICS CORP
RX QUETIAPINE FUMARATE QUETIAPINE FUMARATE A204203 TABLET, EXTENDED RELEASE ORAL EQ 150MG BASE AB LUPIN LTD
RX QUETIAPINE FUMARATE QUETIAPINE FUMARATE A090482 TABLET, EXTENDED RELEASE ORAL EQ 150MG BASE AB PAR PHARMACEUTICAL INC
RX QUETIAPINE FUMARATE QUETIAPINE FUMARATE A206260 TABLET, EXTENDED RELEASE ORAL EQ 150MG BASE AB PHARMADAX INC
RX QUETIAPINE FUMARATE QUETIAPINE FUMARATE A090681 TABLET, EXTENDED RELEASE ORAL EQ 200MG BASE AB ACCORD HEALTHCARE INC


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist